Jason McLellan

Technologies

• Monoclonal antibodies for the conserved feature of the coronavirus spike protein
• Engineered chimeric fusion proteins
• Stabilized coronavirus spike proteins for enhanced vaccine efficacy
• Glycoprotein engineering for hemorrhagic fever virus vaccines
• OPG153-based vaccine for targeted mpox immunization
• Engineered prefusion-stabilized RSV fusion proteins and nucleic acids for enhanced vaccines and diagnostics
• Engineered hantavirus glycoprotein complexes for enhanced vaccines, antibody discovery, and diagnostic applications
• High-yield prefusion stabilized hPIV3 antigens for vaccine and diagnostic development